Ranitidine, widely known by its brand name Zantac, was developed in the late 1970s by GlaxoSmithKline (then Glaxo). The medication was introduced to the market in 1981 as the first revolutionary H2 (histamine-2) receptor antagonist that effectively reduced stomach acid production. Within a few years of its launch, ranitidine became one of the world's best-selling prescription medicati... https://www.coherentmarketinsights.com/market-insight/ranitidine-market-2131